USCOM in Newly Diagnosed FGR Cases

Launched by ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · Mar 27, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring a special ultrasound system called USCOM to better understand heart function in pregnant women diagnosed with fetal growth restriction (FGR). FGR means that the baby is not growing as well as expected, which can happen when the baby’s weight or size is below the 10th percentile for its gestational age. The study aims to see how effectively this ultrasound system can measure how much blood is being pumped by the heart, which is important for monitoring the health of both the mother and the baby during pregnancy.

To participate in this trial, women must be pregnant and have recently been diagnosed with FGR in their third trimester, meaning they are more than 27 weeks along. Unfortunately, those with multiple pregnancies (like twins), certain fetal abnormalities, or diabetes cannot take part in the study. Participants in the trial will receive ultrasound assessments to help improve understanding of their baby's condition. This research is important as it could lead to better ways to monitor and manage pregnancies affected by FGR, ultimately aiming for healthier outcomes for both mothers and babies.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Pregnant patients with a new diagnosis of fetal growth restriction (estimated fetal weight \<10th percentile or abdominal circumference \<10th percentile) in the third trimester (gestational age \>27w6d)
• Exclusion Criteria:
• • Multiple gestation
• • Fetal anomalies
• • Gestational diabetes or pregestational diabetes.